Axon-R

by CognixionUS

An augmented reality headset combining EEG, ssVEP decoding and AI for communication and control. Designed for individuals with paralysis from ALS, locked-in syndrome and spinal cord injury.

PilotStage 3 of 5

Research use only; clinical ALS trials recruiting. FDA clearance pending.

Updated 21 May 2026Checked 10 Oct0 updates this week

Milestones

Next · FDA clearance path initiated
  1. Axon-R announced2024Complete.
  2. Blackrock Neurotech distribution partnershipMay 2025Complete.
  3. FDA clearance path initiatedTarget 2027Not yet reached.
  4. Commercial availabilityTarget 2028Not yet reached.
Primer